Aytu Biopharma Inc (AYTU)

$1.98 +0.03 (1.54%)
Market Cap 12.03M
Revenue (ttm) 81.00M
Net Income (ttm) -15.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.56%
Debt to Equity Ratio 0.61
Volume 285,600
Avg Vol 1,716,540
Day's Range N/A - N/A
Shares Out 6.17M
Stochastic %K 64%
Beta 0.05
Analysts Strong Sell
Price Target $8.00

Company Profile

Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT for patients from six years of age and above, and Cotempla XR-ODT for patients from six to seventeen years old. It also provides pediatric prescription product portfolio comprising Karbinal ER, an extended-release carbinox...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: (720) 437-6580
Website: aytubio.com
Address:
Denver Corporate Center III, Suite 920 7900 East Union Avenue, Denver, United States
Chachix
Chachix Jun. 16 at 11:11 PM
$AYTU Remember That This This Fraudster, Dishbrow is Still Trading After a 200 mil $ were toasted since Covid Times! A Scammer That Will Heal Your Pockets! Hair Paint & Lies At TOPS! J A I L, PoTrash Fuck!!!
0 · Reply
Chachix
Chachix Jun. 15 at 1:35 PM
$AYTU New Hair Paint Presentations by the Retard of the Century, Josh Dishbrow!!!
0 · Reply
ChicagoGuy30
ChicagoGuy30 Jun. 13 at 1:26 PM
$AYTU $4-6 stock
1 · Reply
Love_To_Learn
Love_To_Learn Jun. 13 at 11:49 AM
$BDRX $RFL $MDAI $AYTU and side note $KBSX kids
0 · Reply
Chachix
Chachix Jun. 12 at 9:47 PM
$AYTU si Dishbrow Will Have this Paint healing your lungs from Vovid and Stage 3 Cancer? I mean, Dod Anyone Have Asked Him what Happened With The Covid Tests and The Healight! U know, The ‘’ Tremendous UV Healing Light’’,? Cerecor’s Orphan Desease and Hundreds Of Milion This FELLON DISHBROW Have Toasted, Lying POsHIt!!! Where are The FEDS? HELP!!! JAIL poshit!!!
0 · Reply
Chucky91
Chucky91 Jun. 12 at 4:24 PM
$ZVSA we need more volume!!! $AYTU $BFRI
0 · Reply
PharmaExpert
PharmaExpert Jun. 12 at 3:10 PM
$AKBA, $AYTU, $XBIO, $DWTX, $MREO 🔥🔥🔥🔥🔥
0 · Reply
TONYROSS
TONYROSS Jun. 11 at 9:46 PM
$AYTU Nice presentation. This could be huge.
1 · Reply
MagicalMichael
MagicalMichael Jun. 11 at 8:33 PM
$AYTU 2.40?
0 · Reply
Alain_Simard
Alain_Simard Jun. 11 at 7:27 PM
$AYTU going down cuz folks’ imagination running crazy about what 💩💩💩 is about to go down!
0 · Reply
Latest News on AYTU
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Jun 9, 2025, 4:30 PM EDT - 7 days ago

Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Jun 6, 2025, 8:01 AM EDT - 10 days ago

Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

Jun 6, 2025, 8:00 AM EDT - 10 days ago

Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States

Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript

May 14, 2025, 8:29 PM EDT - 4 weeks ago

Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

May 14, 2025, 4:05 PM EDT - 4 weeks ago

Aytu BioPharma Reports Fiscal 2025 Third Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

May 7, 2025, 4:15 PM EDT - 5 weeks ago

Aytu BioPharma to Report Fiscal 2025 Third Quarter Operational and Financial Results on May 14, 2025

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Apr 21, 2025, 4:05 PM EDT - 2 months ago

Aytu BioPharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript

Feb 12, 2025, 6:27 PM EST - 4 months ago

Aytu BioPharma, Inc. (AYTU) Q2 2025 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Feb 12, 2025, 4:03 PM EST - 4 months ago

Aytu BioPharma Reports Fiscal 2025 Second Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Feb 5, 2025, 5:50 PM EST - 4 months ago

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Jan 6, 2025, 9:00 AM EST - 5 months ago

Aytu BioPharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Aytu BioPharma Disclosure Notification

Dec 3, 2024, 11:45 PM EST - 6 months ago

Aytu BioPharma Disclosure Notification

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Nov 22, 2024, 9:00 AM EST - 7 months ago

Aytu BioPharma Ranked as One of Fastest-Growing Companies in North America on the 2024 Deloitte Technology Fast 500(TM)

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Nov 13, 2024, 7:25 PM EST - 7 months ago

Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Nov 13, 2024, 4:05 PM EST - 7 months ago

Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Nov 6, 2024, 5:20 PM EST - 7 months ago

Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 14, 2024, 4:15 PM EDT - 8 months ago

Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Oct 1, 2024, 8:00 AM EDT - 9 months ago

Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Sep 26, 2024, 6:51 PM EDT - 9 months ago

Aytu BioPharma, Inc. (AYTU) Q4 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Sep 26, 2024, 4:15 PM EDT - 9 months ago

Aytu BioPharma Reports Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Sep 19, 2024, 5:30 PM EDT - 9 months ago

Aytu BioPharma to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on September 26, 2024

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aug 8, 2024, 5:20 PM EDT - 11 months ago

Aytu BioPharma to Participate in the Sidoti Micro-Cap Virtual Conference on August 14-15, 2024

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Aug 6, 2024, 8:00 AM EDT - 11 months ago

Aytu BioPharma Announces Sale of Consumer Health Business Following Wind Down of Consumer Health Operations

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Jun 18, 2024, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

May 15, 2024, 8:28 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

May 15, 2024, 4:05 PM EDT - 1 year ago

Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial Results

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

May 8, 2024, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Apr 3, 2024, 9:00 AM EDT - 1 year ago

Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Feb 14, 2024, 10:52 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Feb 14, 2024, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second Quarter

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Feb 7, 2024, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Jan 23, 2024, 9:00 AM EST - 1 year ago

Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Nov 30, 2023, 8:00 AM EST - 1 year ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Nov 14, 2023, 7:30 PM EST - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Nov 14, 2023, 4:05 PM EST - 1 year ago

Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Nov 8, 2023, 8:30 AM EST - 1 year ago

Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Nov 7, 2023, 4:15 PM EST - 1 year ago

Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Oct 26, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Oct 9, 2023, 4:15 PM EDT - 1 year ago

Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Sep 27, 2023, 7:01 PM EDT - 1 year ago

Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Sep 27, 2023, 4:20 PM EDT - 1 year ago

Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Sep 21, 2023, 8:25 PM EDT - 1 year ago

Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Sep 13, 2023, 8:00 AM EDT - 1 year ago

Aytu BioPharma to Present at LD Micro Main Event XVI Conference

Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority

Jul 31, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority

Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Jul 10, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Submission of Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

Aytu to Participate in the Maxim Group Virtual Healthcare Conference

Jun 14, 2023, 8:00 AM EDT - 2 years ago

Aytu to Participate in the Maxim Group Virtual Healthcare Conference

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market

Jun 13, 2023, 1:45 PM EDT - 2 years ago

Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-Market

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

Jun 9, 2023, 8:00 AM EDT - 2 years ago

Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New Director

Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript

May 11, 2023, 9:57 PM EDT - 2 years ago

Aytu BioPharma, Inc. (AYTU) Q3 2023 Earnings Call Transcript

Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results

May 11, 2023, 4:05 PM EDT - 2 years ago

Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results

Chachix
Chachix Jun. 16 at 11:11 PM
$AYTU Remember That This This Fraudster, Dishbrow is Still Trading After a 200 mil $ were toasted since Covid Times! A Scammer That Will Heal Your Pockets! Hair Paint & Lies At TOPS! J A I L, PoTrash Fuck!!!
0 · Reply
Chachix
Chachix Jun. 15 at 1:35 PM
$AYTU New Hair Paint Presentations by the Retard of the Century, Josh Dishbrow!!!
0 · Reply
ChicagoGuy30
ChicagoGuy30 Jun. 13 at 1:26 PM
$AYTU $4-6 stock
1 · Reply
Love_To_Learn
Love_To_Learn Jun. 13 at 11:49 AM
$BDRX $RFL $MDAI $AYTU and side note $KBSX kids
0 · Reply
Chachix
Chachix Jun. 12 at 9:47 PM
$AYTU si Dishbrow Will Have this Paint healing your lungs from Vovid and Stage 3 Cancer? I mean, Dod Anyone Have Asked Him what Happened With The Covid Tests and The Healight! U know, The ‘’ Tremendous UV Healing Light’’,? Cerecor’s Orphan Desease and Hundreds Of Milion This FELLON DISHBROW Have Toasted, Lying POsHIt!!! Where are The FEDS? HELP!!! JAIL poshit!!!
0 · Reply
Chucky91
Chucky91 Jun. 12 at 4:24 PM
$ZVSA we need more volume!!! $AYTU $BFRI
0 · Reply
PharmaExpert
PharmaExpert Jun. 12 at 3:10 PM
$AKBA, $AYTU, $XBIO, $DWTX, $MREO 🔥🔥🔥🔥🔥
0 · Reply
TONYROSS
TONYROSS Jun. 11 at 9:46 PM
$AYTU Nice presentation. This could be huge.
1 · Reply
MagicalMichael
MagicalMichael Jun. 11 at 8:33 PM
$AYTU 2.40?
0 · Reply
Alain_Simard
Alain_Simard Jun. 11 at 7:27 PM
$AYTU going down cuz folks’ imagination running crazy about what 💩💩💩 is about to go down!
0 · Reply
Wildsens
Wildsens Jun. 11 at 6:57 PM
$AYTU Investor update in 1h 30m
0 · Reply
smokefoeu
smokefoeu Jun. 11 at 1:16 PM
$AYTU trash, JD is a Scamster, Company is a front for getting listed to pay undeserving bonuses🖕🏼
1 · Reply
Wildsens
Wildsens Jun. 11 at 10:45 AM
$AYTU New website: https://aytubio.com/
0 · Reply
GoWhiteSox
GoWhiteSox Jun. 11 at 4:02 AM
$AYTU
1 · Reply
Ice_Wizard
Ice_Wizard Jun. 10 at 10:45 PM
$AYTU 👀
0 · Reply
Alain_Simard
Alain_Simard Jun. 10 at 9:29 PM
$AYTU Jarrett Disbrow purchased 16,666 shares on 6-9-26 for $24,999 per nasdaq.com
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 10 at 9:10 PM
$AYTU CEO purchased 66,666 shares at $1.50 for a total of $99,999. Disbrow Joshua R. now owns 153,257 shares. https://ceo-buys.com
0 · Reply
boomshiva
boomshiva Jun. 10 at 4:34 PM
$AYTU 👀
0 · Reply
MagicalMichael
MagicalMichael Jun. 9 at 11:42 PM
$AYTU ???
0 · Reply
John_D_Stockefeller
John_D_Stockefeller Jun. 9 at 10:09 PM
$AYTU Dimbrow should give all shareholders a free lifetime supply of the anti-depressant. And a free test kit when the boat from China reaches land.
0 · Reply
Alain_Simard
Alain_Simard Jun. 9 at 9:30 PM
$AYTU
0 · Reply
Alain_Simard
Alain_Simard Jun. 9 at 9:28 PM
$AYTU https://finance.yahoo.com/news/aytu-biopharma-announces-closing-upsized-203000590.html
0 · Reply